InsiderClue
Insiders · Profile

Kunkel Lori Anne

Director at Enliven Therapeutics · Director at CURIS. Filing since 23 Jan 2019. CIK 0001536368

ELVN Enliven Therapeutics, Inc. Director · 2 trades CRIS CURIS INC Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
ELVN Enliven Therapeutics, Inc.
6 Jul 2026
Director
Sold on a plan
10,000
$504.90K
19.3%
ELVN Enliven Therapeutics, Inc.
5 Jun 2026
Director
Sold on a plan
10,000
$345.35K
16.2%
CRIS CURIS INC
23 Jan 2019
Director
Sold, plan not stated
14,800
$15.58K
40.0%
3 decisions on file.